SiO2 Materials Science, a privately-owned US-based advanced materials science company, announced they have successfully scaled their manufacturing capacity ahead of schedule to 400 million doses and are on track to hit 1.2 billion capacity before the end of 2020.
Experts around the world have raised concerns about a potential shortage of glass vials needed to deliver a COVID-19 vaccine. SiO2's technology does n ...
Satisfied Users & 
Approved Press Releases
